Skip to main content
The Egyptian Journal of Internal Medicine
Download PDF

HCV co-infection is related to acute ischemic severity and outcome

The Egyptian Journal of Internal Medicine volume 34, Article number: 6 (2022) Cite this article

Abstract

Background and aim

HCV infection is associated with increased risk of ischemic cerebral stroke. HCV stroked patients are younger with a lower burden of classical risk factors and higher levels of systemic inflammation. The present study aimed to discover the association between HCV infection functional outcome of stroke.

Patients and methods

The present prospective study included 60 patients with acute ischemic stroke. All patients were subjected to careful history taking and through clinical and neurological examination. Stroke severity at presentation was assessed using National Institute of Health Stroke Scale (NIHSS). Quantitative HCV RNA test was used to diagnose HCV infection. The prognosis of the studied patients was 3 months after treatment using modified Rankin scale (mRS) for neurologic disability.

Results

The present study was conducted on 60 patients with ischemic stroke. They comprised 13 patients (21.7%) with HCV and 47 patients without. Stroke patients with HCV had significantly higher frequency of carotid artery stenosis, higher NIHSS (17.9 ± 6.9 versus 9.9 ± 5.3, p < 0.001) and higher frequency of severe stroke (46.1% versus 4.3%, p = 0.001) when compared with patients without HCV. Logistic regression analysis identified patients’ sex, NIHSS and HCV as significant predictors of outcome in univariate analysis. However, in multivariate analysis, only NIHSS proved to be significant.

Conclusions

The present study suggests a significant link between chronic HCV infection and ischemic stroke severity and poor outcome. This is probably related to the pathogenic effects of the chronic inflammatory state induced by HCV infection on the cerebral microvasculature.

Introduction

Cerebrovascular stroke is the second most common cause of death after cardiovascular ischemia and the third most common cause of disability worldwide [1]. According to the American Heart Association, 87% of strokes are classified as ischemic [2]. Different modifiable and non-modifiable risk factors have been recognized for stroke. Non-modifiable risk factors are gender, age, ethnicity, heredity, and race. Modifiable risk factors include, but are not limited to, hypertension, dyslipidemia, diabetes mellitus, atrial fibrillation, smoking, drug abuse, and alcoholic intake [3].

Approximately 120 million people are chronically infected with the hepatitis C virus (HCV), and before the era of directly acting viral agents, Egypt had the highest world HCV infection prevalence (20–30%) [4]. HCV infection is associated with increased risk of ischemic cerebral stroke. HCV stroked patients are younger with a lower burden of classical risk factors and higher levels of systemic inflammation [5]. It was also noted that HCV infection is associated with an increased risk of cerebrovascular mortality, particularly for those with elevated serum HCV RNA levels [6]. Moreover, it was shown that stroke patients of HCV positive showed a significantly higher prevalence of carotid atherosclerosis than that observed in the stroke patients and negative HCV [7].

Interestingly, antiviral treatment led to a significant decrease in the risk of stroke after adjusting for known prognostic factors. The beneficial effect of treatment is particularly intriguing, as it provides strong evidence in favor of a pathogenic role for HCV in cerebral vascular diseases [8].

The present study aimed to discover the association between HCV and infection functional outcome of stroke.

Materials and methods

The present prospective study was conducted at Beni-Suef University Hospitals in the period from August 2019 through April 2020. The study protocol was approved the local ethical committee of Beni-Suef Faculty of Medicine and all patients gave informed consent to participate in the study. The study included 60 patients with acute ischemic stroke. Patients were excluded from the study if they have another disabling neurological or systemic disease e.g. epilepsy, malignancy, etc.

All patients were subjected to careful history taking and thorough clinical and neurological examination. Stroke severity at presentation was assessed using National Institute of Health Stroke Scale (NIHSS). Radiological assessment included brain computed tomography (CT) and carotid and vertebrobasilar duplex. Performed laboratory investigations included complete blood count, liver functions, kidney functions, fasting and postprandial blood sugar, HbA1c and lipid profile. Quantitative HCV RNA test was used to diagnose HCV infection. Other performed investigations were ECG and echocardiography. The prognosis of the studied patients was 3 months after treatment using modified Rankin scale (mRS) for neurologic disability.

Data obtained from the present study were statistically analyzed using SPSS 25 (IBM, USA). Numerical variables were presented as mean and standard deviation (SD) while categorical variables were presented as number and percent. Student t test was used to compare numerical variables while chi-square test or Fisher’s exact test were used to compare categorical variables as appropriate. Binary logistic regression was used to identify predictors of the study outcome. P value less than 0.05 was considered statistically significant.

Results

The present study was conducted on 60 patients with ischemic stroke. They comprised 13 patients (21.7%) with HCV and 47 patients without. Comparison between the studied groups regarding the clinical and laboratory data showed that stroke patients with HCV had significantly higher frequency of carotid artery stenosis, higher NIHSS (17.9 ± 6.9 versus 9.9 ± 5.3, p < 0.001) and higher frequency of severe stroke (46.1% versus 4.3%, p = 0.001) when compared with patients without HCV. Moreover, it was shown that HCV + ve patients had significantly higher mRS score (3.6 ± 1.3 versus 2.1 ± 1.3, p = 0.001) and higher frequency of cases with unfavorable outcome (76.9% versus 36.2%, p = 0.005) when compared with patients without HCV (Table 1).

Table 1 Demographic, clinical and outcome parameters in the studies patients (n = 60)
Full size table

Logistic regression analysis identified patients’ sex [OR (95% CI): 3.6 (1.1–11.5), p = 0.031], NIHSS [OR (95% CI): 2.5 (1.4–4.3), p = 0.001] and HCV [OR (95% CI): 5.9 (1.4–24.4), p = 0.015] as significant predictors of outcome in univariate analysis. However, in multivariate analysis, only NIHSS proved to be significant [OR (95% CI): 2.8 (1.4–5.5), p = 0.002] (Table 2).

Table 2 Predictors of unfavorable outcome in the studied patients
Full size table

Discussion

The aim of this work to study the possible relation between HCV infection and ischemic stroke severity and outcome. Among the studied patients, there were 13 patients (21.7%) with HCV. Comparative analysis revealed that HCV patients had significantly higher frequency of carotid artery stenosis. This agreed with El-Azab et al., [7] who showed that stroke patients of HCV showed a significantly higher prevalence of carotid atherosclerosis than that observed in the stroke patients without HCV. Similar conclusions were reported by other studies [9,10,11]. Interestingly, a meta-analysis found that compared with individuals without HCV, patients with HCV had a higher risk for carotid atherosclerosis, cerebrocardiovascular events such as ischemic stroke and myocardial infarction, and death resulting from cardiovascular disease [12].

In the present study, HCV patients had significantly higher NIHSS and higher frequency of severe stroke when compared with their counterparts without HCV. The association between HCV and severity of ischemic stroke is a novel finding. Infectious agents may play as a stimulus for atherothrombosis [13, 14] by triggering a cascade of immune responses and inflammatory stimuli either locally within vascular tissue or systemically through inflammatory mediators [15].

In addition, the present study noted that HCV patients had significantly higher prevalence of unfavorable outcome. While HCV was considered a significant predictor of stroke outcome in univariate analysis, only NIHSS remained significant in multivariate analysis. Patients with persistent HCV infection had increased circulating levels of inflammation markers such as C-reactive protein and endothelial progenitor cells. This may provide insights on the mechanisms involved in the link between HCV infection and cerebrovascular disease [16, 17].

In conclusion, the present study suggests a significant link between chronic HCV infection and ischemic stroke severity and poor outcome. This is probably related to the pathogenic effects of the chronic inflammatory state induced by HCV infection on the cerebral microvasculature.

Availability of data and materials

Data of this research will be available upon reasonable request.

References

  1. Feigin VL, Norrving B, Mensah GA (2017) Global burden of stroke. Circ Res 120(3):439–448. https://doi.org/10.1161/CIRCRESAHA.116.308413 PMID: 28154096

    Article  CAS  PubMed  Google Scholar 

  2. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB (2012) American Heart Association statistics committee and stroke statistics subcommittee. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation 125(1):e2–e220. https://doi.org/10.1161/CIR.0b013e31823ac046 Epub 2011 Dec 15. Erratum in: Circulation. 2012 Jun 5;125(22):e1002. PMID: 22179539; PMCID: PMC4440543

    Article  PubMed  Google Scholar 

  3. Zafar A, Al-Khamis FA, Al-Bakr AI, Alsulaiman AA, Msmar AH (2016) Risk factors and subtypes of acute ischemic stroke. A study at king Fahd Hospital of the University. Neurosciences (Riyadh) 21(3):246–251. https://doi.org/10.17712/nsj.2016.3.20150731 PMID: 27356657; PMCID: PMC5107292

    Article  Google Scholar 

  4. Mohamoud YA, Mumtaz GR, Riome S, Miller D, Abu-Raddad LJ (2013) The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis. BMC Infect Dis 13:288. https://doi.org/10.1186/1471-2334-13-288 PMID: 23799878; PMCID: PMC3702438

    Article  PubMed  PubMed Central  Google Scholar 

  5. Restivo L, Iuliano N, Nevola R, Amelia A, Fascione MC, Adinolfi LE (2013) T-02 chronic HCV infection and extrahepatic diseases: ischemic stroke and ischemic heart disease. Dig Liver Dis 45:S13

    Article  Google Scholar 

  6. Lee MH, Yang HI, Wang CH, Jen CL, Yeh SH, Liu CJ, You SL, Chen WJ, Chen CJ (2010) Hepatitis C virus infection and increased risk of cerebrovascular disease. Stroke. 41(12):2894–2900. https://doi.org/10.1161/STROKEAHA.110.598136 Epub 2010 Oct 21. PMID: 20966408

    Article  PubMed  Google Scholar 

  7. El-Azab MH, El Naser AMA, Khodair AZA, Moselhy KS, Youseif AA (2016) A study of some risk factors of ischemic stroke in patients with hepatitis C viral infection. J Am Sci 12(2)

  8. Negro F (2014) Hepatitis C in 2013: HCV causes systemic disorders that can be cured. Nat Rev Gastroenterol Hepatol 11(2):77–78. https://doi.org/10.1038/nrgastro.2013.222 Epub 2013 Nov 26. PMID: 24275792

    Article  CAS  PubMed  Google Scholar 

  9. Adinolfi LE, Restivo L, Guerrera B, Sellitto A, Ciervo A, Iuliano N, Rinaldi L, Santoro A, Li Vigni G, Marrone A (2013) Chronic HCV infection is a risk factor of ischemic stroke. Atherosclerosis 231(1):22–26. https://doi.org/10.1016/j.atherosclerosis.2013.08.003 Epub 2013 Aug 15. PMID: 24125405

    Article  CAS  PubMed  Google Scholar 

  10. Ishizaka Y, Ishizaka N, Takahashi E, Unuma T, Tooda E, Hashimoto H, Nagai R, Yamakado M (2003) Association between hepatitis C virus core protein and carotid atherosclerosis. Circ J 67(1):26–30. https://doi.org/10.1253/circj.67.26 PMID: 12520147

    Article  CAS  PubMed  Google Scholar 

  11. Fawi G, Elhewag HK, Elnady HM, Mohamed A-AB, Ezzat A, Hefny HM, Islam MS-A, Alam-Eldeen MH (2015) Characteristics of ischemic stroke in asymptomatic hepatitis C virus positive patients. J Am Sci 11(9)

  12. Petta S, Maida M, Macaluso FS, Barbara M, Licata A, Craxì A, Cammà C (2016) Hepatitis C virus infection is associated with increased cardiovascular mortality: a meta-analysis of observational studies. Gastroenterology 150(1):145–155. https://doi.org/10.1053/j.gastro.2015.09.007 e4; quiz e15–6. Epub 2015 Sep 18. PMID: 26386298

    Article  PubMed  Google Scholar 

  13. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Victor A, Hafner G, Prellwitz W, Schlumberger W, Meyer J (2002) Impact of infectious burden on progression of carotid atherosclerosis. Stroke 33(11):2581–2586. https://doi.org/10.1161/01.str.0000034789.82859.a4 PMID: 12411646

    Article  CAS  PubMed  Google Scholar 

  14. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P (2004) Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 351(25):2611–2618. https://doi.org/10.1056/NEJMoa041747 PMID: 15602021

    Article  CAS  PubMed  Google Scholar 

  15. Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352(16):1685–1695. https://doi.org/10.1056/NEJMra043430 PMID: 15843671

    Article  CAS  PubMed  Google Scholar 

  16. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Böhm M, Nickenig G (2005) Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353(10):999–1007. https://doi.org/10.1056/NEJMoa043814 PMID: 16148285

    Article  CAS  PubMed  Google Scholar 

  17. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, Curhan GC, Rifai N, Cannuscio CC, Stampfer MJ, Rimm EB (2004) Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 351(25):2599–2610. https://doi.org/10.1056/NEJMoa040967 PMID: 15602020

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

None.

Funding

None.

Author information

Authors and Affiliations

  1. Department of Neurology, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt

    Mohammed M. Masoud, Hany A. Sayed & Hatem A. El Masry

  2. Department of Clinical Pathology, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt

    Shaimaa A. Abdelkareem

Authors
  1. Mohammed M. Masoud
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hany A. Sayed
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hatem A. El Masry
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shaimaa A. Abdelkareem
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Mohammed M. Masoud, has contributed to the research by designing and supervision. Hany A. Sayed, has contributed to the research by writing and data collection. Hatem A. El Masry, has contributed to the research by reviewing. Shaimaa A Abdelkareem, has contributed to the research by data collection and reviewing. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Mohammed M. Masoud.

Ethics declarations

Ethics approval and consent to participate

The present study was approved by the ethical committee of Beni-Suef Faculty of medicine (Approval number: 208/11) at March, 1, 2019.

Consent for publication

All patients or their legal guardians gave informed consent to participate in the study.

Competing interests

The authors declare no conflict of interest, financial or otherwise.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Masoud, M.M., Sayed, H.A., El Masry, H.A. et al. HCV co-infection is related to acute ischemic severity and outcome. Egypt J Intern Med 34, 6 (2022). https://doi.org/10.1186/s43162-021-00095-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s43162-021-00095-4

Keywords